Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

被引:24
|
作者
Verselis, SJ
Rheinwald, JG
Fraumeni, JF
Li, FP [1 ]
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Skin Dis Res Ctr, Boston, MA 02115 USA
[5] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
关键词
p53; germline mutation; Li-Fraumeni syndrome; alternate splicing;
D O I
10.1038/sj.onc.1203758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline mutations in the p53 tumor suppressor gene predispose to a variety of cancers in families with Li-Fraumeni syndrome. Most germline p53 mutations observed to date cause amino acid substitutions in the protein's central sequence-specific DNA binding domain. Outside this conserved core region, however, we found novel alterations in sequences that regulate precursor mRNA splicing in three Li-Fraumeni syndrome families. Two splice site mutations affected the consensus sequence at the splice donor sites of introns 1 and 9, and produced unstable variant transcripts in normal cells. A third mutation at the splice acceptor site of intron 9 generated splicing at a cryptic acceptor site in intron 9, These splice site alterations emphasize the need to examine both noncoding and untranslated regions of the p53 gene for germline mutations in Li-Fraumeni syndrome families.
引用
收藏
页码:4230 / 4235
页数:6
相关论文
共 50 条
  • [31] Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
    Jie Xu
    Jin Qian
    Ye Hu
    Jilin Wang
    Xiaolin Zhou
    Haoyan Chen
    Jing-Yuan Fang
    Scientific Reports, 4
  • [32] Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
    Xu, Jie
    Qian, Jin
    Hu, Ye
    Wang, Jilin
    Zhou, Xiaolin
    Chen, Haoyan
    Fang, Jing-Yuan
    SCIENTIFIC REPORTS, 2014, 4
  • [33] Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family
    Evans, SC
    Mims, B
    McMasters, KM
    Foster, CJ
    deAndrade, M
    Amos, CI
    Strong, LC
    Lozano, G
    HUMAN GENETICS, 1998, 102 (06) : 681 - 686
  • [34] Inherited TP53 Mutations and the Li-Fraumeni Syndrome
    Guha, Tanya
    Malkin, David
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (04):
  • [35] Germline TP53 mutations and Li-Fraumeni syndrome
    Varley, JM
    HUMAN MUTATION, 2003, 21 (03) : 313 - 320
  • [36] p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
    Quesnel, S
    Verselis, S
    Portwine, C
    Garber, J
    White, M
    Feunteun, J
    Malkin, D
    Li, FP
    ONCOGENE, 1999, 18 (27) : 3970 - 3978
  • [37] Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family
    Susan C. Evans
    Betsy Mims
    Kelly M. McMasters
    Carolyn J. Foster
    Mariza deAndrade
    Christopher I. Amos
    Louise C. Strong
    Guillermina Lozano
    Human Genetics, 1998, 102 : 681 - 686
  • [38] Investigating the interaction between the microbiome and mutant p53 in Li-Fraumeni Syndrome
    Ong, Noel Wei
    Giovino, Camilla Maria
    Fischer, Nicholas William
    Psarianos, Pamela
    Malkin, David
    CANCER RESEARCH, 2022, 82 (12)
  • [39] p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
    Susan Quesnel
    Sigitas Verselis
    Carol Portwine
    Judy Garber
    Marga White
    Jean Feunteun
    David Malkin
    Frederick P Li
    Oncogene, 1999, 18 : 3970 - 3978
  • [40] Li-Fraumeni syndrome, P53 gene, rhabdomyosarcomaRhabdomyosarcoma in a patient with germline TP53 gene mutations: A case report
    Chen, Li-Ping
    Zhang, Wei-Ling
    Huang, Dong-Sheng
    KUWAIT MEDICAL JOURNAL, 2020, 52 (04): : 450 - 454